Determination the effect of calcium and vitamin B12 co-supplementation on some anthropometric indices, blood glucose, lipid profile and blood pressure in Individuals with metabolic syndrome

Phase 3

Recruiting

• Conditions: Metabolic syndrome.; Metabolic syndrome; E88.81

• Registration Number: IRCT20230416057916N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 56

Inclusion Criteria

Individuals with metabolic syndrome according to ATP III criteria who tend to participate in research Age range of 18-65 years old.
Not suffering from kidney, liver, chronic diseases, malignancies, and systemic diseases.
Not supplementation of calcium, vitamin B12, chromium, magnesium, and vitamin D for the past 3 months before the study.

Exclusion Criteria

pregnant and lactating women

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum insulin. Timepoint: At the beginning of the study (before the intervention) and the end of the study (8 weeks after the intervention). Method of measurement: Enzyme-linked immuno_sorbent assay (ELISA) kit.;Blood glucose. Timepoint: At the beginning of the study (before the intervention) and the end of the study (8 weeks after the intervention). Method of measurement: Calorimetric Laboratory.;HOMA-IR index. Timepoint: At the beginning of the study (before the intervention) and the end of the study (8 weeks after the intervention). Method of measurement: (Glucose ×insulin)/405.